Mindfulness, Self-Compassion Training Improves QOL in Eczema

WEDNESDAY, May 10, 2023 (HealthDay News) -- A mindfulness and self-compassion training intervention is effective for improving quality of life (QOL) among adults with atopic dermatitis, according to a study published online May 10 in JAMA Dermatology.
Sanae Kishimoto, M.P.H., from Kyoto University in Japan, and colleagues examined the efficacy of mindfulness and self-compassion training in improving QOL for adults with atopic dermatitis in a randomized clinical trial. A total of 107 adults were randomly assigned to receive eight 90-minute weekly group sessions of online mindfulness and self-compassion training or to a waiting list (56 and 51 patients, respectively).
The researchers observed a greater improvement in the Dermatology Life Quality Index score at 13 weeks in the intervention group (between-group difference estimate, −6.34). At 13 weeks, the standardized effect size (Cohen d) was −1.06. Greater improvements were seen in the intervention versus the waiting-list group for all secondary outcomes, including eczema severity, itch- and scratching-related visual analog scales, self-compassion and all of its subscales, mindfulness, psychological symptoms, and participants' adherence to dermatologist-advised treatments.
"The present study is the first, to our knowledge, to show that group-format mindfulness and self-compassion enhances the QOL for adults with atopic dermatitis," the authors write.
Several authors disclosed financial ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Morning Exercise Tied to Larger Cuts in Cardiovascular Disease Risk
WEDNESDAY, Nov. 23, 2022 (HealthDay News) -- Physical activity in the morning is...
Machine Learning Algorithm Can Predict Diabetes From ECG
WEDNESDAY, Aug. 10, 2022 (HealthDay News) -- A machine learning algorithm can...
BNT162b2 Vaccine Effective Against Severe COVID-19 in Adolescents
WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- Two doses of the BNT162b2 vaccine...
Un ‘páncreas artificial’ mejora el control del azúcar en la sangre en los niños con diabetes tipo 1
VIERNES, 17 de marzo de 2023 (HealthDay News) -- Igual que los adultos, los...